πŸ‡ΊπŸ‡Έ FDA
Patent

US 10196425

Peptide compositions

granted A61KA61K38/00A61K38/12

Quick answer

US patent 10196425 (Peptide compositions) held by RHYTHM PHARMACEUTICALS, INC. expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RHYTHM PHARMACEUTICALS, INC.
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/00, A61K38/12, A61P, A61P1/16